Therefore, it is clear that DIM activity in breast cancer may be due, in part, to inhibitory AhR–ER crosstalk, but multiple growth inhibitory/cell death pathways impacting breast and other cancer cell lines induced by DIM are AhR-independent [97]. Here, AHR is linked to breast carcinoma.